These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21273391)

  • 1. Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension.
    Chen H; De Marco T; Kobashigawa EA; Katz PP; Chang VW; Blanc PD
    Eur Respir J; 2011 Sep; 38(3):608-16. PubMed ID: 21273391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impression life with pulmonary hypertension: clinically relevant characteristics and quality of life among patients in Gansu, China.
    Zhang J; Wen Y; Yin Y; Zhang Y; Zhang R; Zhang X; Ye J; Feng Y; Meng H
    Ther Adv Respir Dis; 2024; 18():17534666241246428. PubMed ID: 38676370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study.
    Gerhardt F; Dumitrescu D; Gärtner C; Beccard R; Viethen T; Kramer T; Baldus S; Hellmich M; Schönau E; Rosenkranz S
    Heart; 2017 Apr; 103(8):592-598. PubMed ID: 28100544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension.
    Zlupko M; Harhay MO; Gallop R; Shin J; Archer-Chicko C; Patel R; Palevsky HI; Taichman DB
    Respir Med; 2008 Oct; 102(10):1431-8. PubMed ID: 18617379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension.
    Mathai SC; Suber T; Khair RM; Kolb TM; Damico RL; Hassoun PM
    Ann Am Thorac Soc; 2016 Jan; 13(1):31-9. PubMed ID: 26492065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-Related Quality of Life in Pulmonary Hypertension and Its Clinical Correlates: A Cross-Sectional Study.
    Reis A; Santos M; Vicente M; Furtado I; Cruz C; Melo A; Carvalho L; Gonçalves F; Sa-Couto P; Almeida L
    Biomed Res Int; 2018; 2018():3924517. PubMed ID: 29750153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension.
    Balasubramanian A; Larive AB; Horn EM; DuBrock HM; Mehra R; Jacob MS; Hemnes AR; Leopold JA; Radeva MK; Hill NS; Erzurum SC; Rosenzweig EB; Frantz RP; Rischard FP; Beck GJ; Hassoun PM; Mathai SC;
    Chest; 2024 Jun; 165(6):1493-1504. PubMed ID: 38354903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise capacity affects quality of life in patients with pulmonary hypertension.
    Halank M; Einsle F; Lehman S; Bremer H; Ewert R; Wilkens H; Meyer FJ; Grünig E; Seyfarth HJ; Kolditz M; Wieder G; Höffken G; Köllner V
    Lung; 2013 Aug; 191(4):337-43. PubMed ID: 23681593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of tight association between quality of life and exercise capacity in pulmonary arterial hypertension.
    Cícero C; Franchi SM; Barreto AC; Lopes AA
    Arq Bras Cardiol; 2012 Oct; 99(4):876-85. PubMed ID: 22936028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment.
    Mathai SC; Minai O; Sullivan SD; Lerner D; Levine D
    Respir Med; 2017 Jan; 122 Suppl 1():S23-S27. PubMed ID: 27890471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.
    Mehta S; Sastry BKS; Souza R; Torbicki A; Ghofrani HA; Channick RN; Delcroix M; Pulido T; Simonneau G; Wlodarczyk J; Rubin LJ; Jansa P; Hunsche E; Galiè N; Perchenet L; Sitbon O
    Chest; 2017 Jan; 151(1):106-118. PubMed ID: 27671974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension.
    Sanges S; Launay D; Rhee RL; Sitbon O; Hachulla É; Mouthon L; Guillevin L; Rottat L; Montani D; De Groote P; Cottin V; Magro P; Prévot G; Bauer F; Bergot E; Chabanne C; Reynaud-Gaubert M; Leroy S; Canuet M; Sanchez O; Gut-Gobert C; Dauphin C; Pison C; Boissin C; Habib G; Clerson P; Conesa F; Cordier JF; Kawut SM; Simonneau G; Humbert M
    Ann Rheum Dis; 2016 Aug; 75(8):1457-65. PubMed ID: 26324844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
    Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
    J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension.
    Halimi L; Marin G; Molinari N; Gamez AS; Boissin C; Suehs CM; Vachier I; Bourdin A
    J Psychosom Res; 2018 Feb; 105():45-51. PubMed ID: 29332633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of an activity monitor in the objective evaluation of patients with pulmonary hypertension.
    Okumus G; Aslan GK; Arseven O; Ongen G; Issever H; Kiyan E
    Clin Respir J; 2018 Jan; 12(1):119-125. PubMed ID: 27149246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.
    Saxer S; Lichtblau M; Berlier C; Hasler ED; Schwarz EI; Ulrich S
    Lung; 2019 Oct; 197(5):617-625. PubMed ID: 31263960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emotional symptoms and quality of life in patients with pulmonary arterial hypertension.
    M M Vanhoof J; Delcroix M; Vandevelde E; Denhaerynck K; Wuyts W; Belge C; Dobbels F
    J Heart Lung Transplant; 2014 Aug; 33(8):800-8. PubMed ID: 24854567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom Interference Severity and Health-Related Quality of Life in Pulmonary Arterial Hypertension.
    Matura LA; McDonough A; Carroll DL
    J Pain Symptom Manage; 2016 Jan; 51(1):25-32. PubMed ID: 26300023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Pulmonary Arterial Hypertension Using Initial Combination Therapy of Bosentan and Iloprost.
    Han X; Zhang Y; Dong L; Fang L; Chai Y; Niu M; Yu Y; Liu L; Yang X; Qu S; Li S
    Respir Care; 2017 Apr; 62(4):489-496. PubMed ID: 28119496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension.
    Chaouat A; Sitbon O; Mercy M; Ponçot-Mongars R; Provencher S; Guillaumot A; Gomez E; Selton-Suty C; Malvestio P; Regent D; Paris C; Hervé P; Chabot F
    Eur Respir J; 2014 Sep; 44(3):704-13. PubMed ID: 24833765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.